China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations, The Foote
China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Call Transcript
Categories
Health Care
Is it the right time to invest in Agilent Technologies (A)?
Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown in the
Medtronic PLC (MDT) Q2 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2021 earnings call dated Nov. 24, 2020 Corporate Participants: Ryan Weispfenning -- Vice President - Head of Investor Relations
Infographic: How Medtronic (MDT) performed in Q2 financial results
Medtronic plc (NYSE: MDT) reported second quarter 2021 earnings results today. Worldwide revenue was $7.64 billion, down 0.8% on a reported basis
Agilent Technologies Inc. (A) Q4 2020 Earnings Call Transcript
Agilent Technologies Inc. (NYSE: A) Q4 2020 earnings call dated Nov. 23, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
COVID-19 vaccine: These pharma companies have also made headway
The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for the development
Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov
10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went public more
Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days
Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Palatin Technologies, Inc. (PTN) Q1 2021 Earnings Call Transcript
Palatin Technologies, Inc. (AMEX: PTN) Q1 2021 earnings call dated Nov. 17, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer Stephen
COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others?
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine
Moderna (MRNA) gains as COVID-19 vaccine candidate shows over 94% efficacy
Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive results from
Bio-Path Holdings, Inc. (BPTH) Q3 2020 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q3 2020 earnings call dated Nov. 13, 2020 Corporate Participants: Will O'Connor -- Stern Investor Relations Peter Nielsen -- President, Chief
Biocept Inc (BIOC) Q3 2020 Earnings Call
Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss -- Investor Relations Michael W. Nall -- President and Chief
Beyond Air (XAIR) has hopes pinned on these two product opportunities for next year
Shares of Beyond Air Inc. (NASDAQ: XAIR) gained over 3% in midday trade on Thursday. The stock has climbed 5% since the
PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Call Transcript
PDL BioPharma, Inc. (NASDAQ: PDLI) Q3 2020 earnings call dated Nov. 11, 2020 Corporate Participants: Jody Cain -- Senior Vice President, LHA Dominique Monnet -- President
Beyond Air, Inc. (XAIR) Q2 2021 Earnings Call Transcript
Beyond Air, Inc. (NASDAQ: XAIR) Q2 2021 earnings call dated Nov. 11, 2020 Corporate Participants: Maria Yonkoski -- Head of Investor Relations Steve Lisi -- Chief
Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback
The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA issued a
10x Genomics, Inc. (TXG) Q3 2020 Earnings Call Tanscript
10x Genomics, Inc. (NASDAQ: TXG) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations and Strategic
Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript
Affimed N.V. (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive
Aurora Cannabis Inc. (ACB) Q1 2021 Earnings Call Transcript
Aurora Cannabis Inc. (NYSE: ACB) Q1 2021 earnings call dated Nov. 09, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer Glen Ibbott -- Chief Financial